AFRICA – Kintor Pharmaceutical Limited has announced that it has entered into a licensing agreement with Shanghai Fosun Pharmaceutical Development on the commercialization of proxalutamide for the treatment of COVID-19…
Read MoreAFRICA – Kintor Pharmaceutical Limited has announced that it has entered into a licensing agreement with Shanghai Fosun Pharmaceutical Development on the commercialization of proxalutamide for the treatment of COVID-19…
Read More